US Stock MarketDetailed Quotes

COEP Coeptis Therapeutics

Watchlist
  • 0.350
  • -0.005-1.46%
Close May 17 16:00 ET
  • 0.350
  • 0.000-0.03%
Post 19:49 ET
13.00MMarket Cap-686P/E (TTM)

Coeptis Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0
0
0
0
0
Operating expense
-55.31%2.92M
-37.15%21.49M
4.55%3.37M
43.34%7.9M
-62.20%3.68M
-58.39%6.54M
142.17%34.2M
5.89%3.22M
-18.45%5.51M
277.73%9.75M
Selling and administrative expenses
-69.30%1.9M
-56.63%14.82M
-26.92%2.35M
-48.50%2.83M
-66.99%3.22M
-60.72%6.17M
142.02%34.18M
5.89%3.22M
-18.76%5.49M
277.73%9.75M
-Selling and marketing expense
----
52.56%12.71K
-100.07%-1
334.14%12.41K
-92.60%300
----
185.50%8.33K
--1.42K
--2.86K
--4.05K
-General and administrative expense
-69.30%1.9M
-56.65%14.81M
-26.89%2.35M
-48.70%2.82M
-66.98%3.22M
-60.72%6.17M
142.01%34.17M
5.84%3.22M
-18.80%5.49M
277.57%9.74M
Research and development costs
573.78%777.07K
31,825.33%6.67M
--1.01M
24,187.54%5.07M
--466.63K
--115.33K
--20.89K
--0
--20.89K
--0
Depreciation amortization depletion
0.00%250K
----
----
----
----
--250K
----
----
----
----
-Depreciation and amortization
0.00%250K
----
----
----
----
--250K
----
----
----
----
Operating profit
55.31%-2.92M
37.15%-21.49M
-4.55%-3.37M
-43.34%-7.9M
62.20%-3.68M
58.39%-6.54M
-143.46%-34.2M
-5.89%-3.22M
18.45%-5.51M
-277.73%-9.75M
Net non-operating interest income expense
-538.21%-200.51K
50.70%-107.69K
67.33%-13.83K
64.91%-19.8K
33.20%-42.64K
43.72%-31.42K
-16.71%-218.41K
-153.43%-42.34K
70.08%-56.42K
-48.10%-63.83K
Non-operating interest expense
538.21%200.51K
-50.70%107.69K
-67.33%13.83K
-64.91%19.8K
-33.20%42.64K
-43.72%31.42K
16.71%218.41K
153.43%42.34K
-70.08%56.42K
48.10%63.83K
Other net income (expense)
108.76%121.5K
110.52%332.27K
-217.91%-375.79K
2,063.16%1.57M
5,141.09%525K
59.29%-1.39M
-503.15%-3.16M
162.50%318.7K
-107.99%-80K
111.23%10.02K
Gain on sale of security
102.51%34.88K
--567.75K
---178.88K
--1.61M
--525K
---1.39M
----
----
----
----
Special income (charges)
----
--0
--0
--0
--0
----
-169,577.10%-3.39M
--0
--0
-80.62%15.02K
-Less:Other special charges
----
----
----
----
----
----
--3.39M
--0
----
80.62%-15.02K
Other non- operating income (expenses)
247,400.00%86.63K
-200.76%-235.48K
-161.79%-196.91K
51.75%-38.6K
----
--35
-70.26%233.7K
162.50%318.7K
-107.97%-80K
97.00%-5K
Income before tax
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Net income continuous Operations
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Minority interest income
Net income attributable to the parent company
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Basic earnings per share
80.00%-0.08
68.44%-0.83
53.46%-0.07
17.08%-0.24
68.72%-0.15
57.37%-0.4
-299.72%-2.63
-8.27%-0.1504
0.51%-0.2894
-261.30%-0.4796
Diluted earnings per share
80.00%-0.08
68.44%-0.83
53.46%-0.07
17.08%-0.24
68.72%-0.15
57.37%-0.4
-299.72%-2.63
-8.27%-0.1504
0.51%-0.2894
-261.30%-0.4796
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000000000
Gross profit 0000000000
Operating expense -55.31%2.92M-37.15%21.49M4.55%3.37M43.34%7.9M-62.20%3.68M-58.39%6.54M142.17%34.2M5.89%3.22M-18.45%5.51M277.73%9.75M
Selling and administrative expenses -69.30%1.9M-56.63%14.82M-26.92%2.35M-48.50%2.83M-66.99%3.22M-60.72%6.17M142.02%34.18M5.89%3.22M-18.76%5.49M277.73%9.75M
-Selling and marketing expense ----52.56%12.71K-100.07%-1334.14%12.41K-92.60%300----185.50%8.33K--1.42K--2.86K--4.05K
-General and administrative expense -69.30%1.9M-56.65%14.81M-26.89%2.35M-48.70%2.82M-66.98%3.22M-60.72%6.17M142.01%34.17M5.84%3.22M-18.80%5.49M277.57%9.74M
Research and development costs 573.78%777.07K31,825.33%6.67M--1.01M24,187.54%5.07M--466.63K--115.33K--20.89K--0--20.89K--0
Depreciation amortization depletion 0.00%250K------------------250K----------------
-Depreciation and amortization 0.00%250K------------------250K----------------
Operating profit 55.31%-2.92M37.15%-21.49M-4.55%-3.37M-43.34%-7.9M62.20%-3.68M58.39%-6.54M-143.46%-34.2M-5.89%-3.22M18.45%-5.51M-277.73%-9.75M
Net non-operating interest income expense -538.21%-200.51K50.70%-107.69K67.33%-13.83K64.91%-19.8K33.20%-42.64K43.72%-31.42K-16.71%-218.41K-153.43%-42.34K70.08%-56.42K-48.10%-63.83K
Non-operating interest expense 538.21%200.51K-50.70%107.69K-67.33%13.83K-64.91%19.8K-33.20%42.64K-43.72%31.42K16.71%218.41K153.43%42.34K-70.08%56.42K48.10%63.83K
Other net income (expense) 108.76%121.5K110.52%332.27K-217.91%-375.79K2,063.16%1.57M5,141.09%525K59.29%-1.39M-503.15%-3.16M162.50%318.7K-107.99%-80K111.23%10.02K
Gain on sale of security 102.51%34.88K--567.75K---178.88K--1.61M--525K---1.39M----------------
Special income (charges) ------0--0--0--0-----169,577.10%-3.39M--0--0-80.62%15.02K
-Less:Other special charges --------------------------3.39M--0----80.62%-15.02K
Other non- operating income (expenses) 247,400.00%86.63K-200.76%-235.48K-161.79%-196.91K51.75%-38.6K------35-70.26%233.7K162.50%318.7K-107.97%-80K97.00%-5K
Income before tax 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Income tax 0000000000
Net income 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Net income continuous Operations 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Minority interest income
Net income attributable to the parent company 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Basic earnings per share 80.00%-0.0868.44%-0.8353.46%-0.0717.08%-0.2468.72%-0.1557.37%-0.4-299.72%-2.63-8.27%-0.15040.51%-0.2894-261.30%-0.4796
Diluted earnings per share 80.00%-0.0868.44%-0.8353.46%-0.0717.08%-0.2468.72%-0.1557.37%-0.4-299.72%-2.63-8.27%-0.15040.51%-0.2894-261.30%-0.4796
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg